LIPCAR, Cuproptosis, and Α-SMA in the Pathogenesis of AMI and Remodeling

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

July 31, 2027

Conditions
Acute Myocardial Infarction (AMI)
Interventions
GENETIC

blood sampling

"The followings markers will be investigated in plasma samples:~1. LIPCAR, STAT3 and DDIT3 using quantitative real-time polymerase chain reaction (qRT-PCR)~2. α-SMA using western blot analysis~3. Troponin T using ELISA expression~4. Serum levels of fasting blood glucose (FBG), total cholesterol (TC), triglycerides (TG), and high-density lipoprotein cholesterol (HDL-C), oxidized low-density lipoprotein (ox-LDL) using chemical methods (spectrophotometry). The Friedewald formula was used to compute low-density lipoprotein cholesterol (LDL-C): LDL-Cholesterol =Total cholesterol- (HDL-Cholesterol +Triglycerides/5)."

All Listed Sponsors
lead

Assiut University

OTHER

NCT06833918 - LIPCAR, Cuproptosis, and Α-SMA in the Pathogenesis of AMI and Remodeling | Biotech Hunter | Biotech Hunter